NORMAL SITUATION

bmedi

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
36,7 k €
-59.6% YoY
Revenue
1,2 M €
-26.8% YoY
Equity
359,1 k €
+11.4% YoY
Workforce
1,0 ETP
-47.4% YoY

Company — Normal situation.

What does bmedi do?

bmedi is a company registered in Belgium. It employs on average 1,0 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0840.816.091
Legal form
Private limited company
Contributed capital
14 000,00 €
Latest accounts
31/12/2025
Average workforce
1,0 ETP
Joint committees (2)
  • 100
  • 200
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 14 financial years

20252024202320222021202020192018201720162015201420132012
Income statement
Revenue1,2 M €1,7 M €––––––––––––
EBITDA39,8 k €131,7 k €260,8 k €72,5 k €22,7 k €145,5 k €62,8 k €115,2 k €93,7 k €36,3 k €-24,5 k €23,4 k €18,4 k €12,2 k €
Operating result59,2 k €101,6 k €259,5 k €82,3 k €10,4 k €107,2 k €34,2 k €92 k €69,7 k €12,1 k €-69,5 k €21,9 k €17,1 k €10,7 k €
Net result36,7 k €90,8 k €181 k €57,8 k €4,8 k €72 k €16,9 k €69,1 k €50,4 k €1,3 k €-57,3 k €13,4 k €8,7 k €4,7 k €
Balance sheet
Equity359,1 k €322,4 k €231,6 k €250,6 k €192,9 k €188,1 k €116,1 k €99,2 k €30,1 k €-20,3 k €-21,6 k €35,7 k €27,4 k €18,7 k €
Total assets826,7 k €1,2 M €696,3 k €611,5 k €721,4 k €921 k €728 k €685,3 k €583 k €516,4 k €506,6 k €169,1 k €154,1 k €50,2 k €
Cash38,9 k €24,1 k €29,8 k €338 k €149,7 k €160,2 k €119,7 k €199,7 k €83,1 k €14 k €8,6 k €12,5 k €64,5 k €13 k €
Debts416,4 k €835,6 k €464,7 k €360,9 k €528,6 k €732,9 k €611,9 k €586,1 k €552,9 k €536,4 k €528,2 k €133,4 k €126,7 k €30,3 k €
Other
Workforce1,0 ETP1,9 ETP2,0 ETP2,2 ETP3,1 ETP2,9 ETP2,9 ETP2,5 ETP2,9 ETP2,8 ETP3,1 ETP2,4 ETP0,3 ETP–
Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 11 ended

Active mandates

Bobbie Pharmaceutical Services

Managing director · since 19 août 2025 · 0799.344.237

Represented by Benoit Devroe

Active
Bobbie Company

Director · since 16 mars 2023 · until 19 août 2025 · 0685.530.177

Represented by Benoit Devroe

Active
Cecile Hoogmartens

Director · since 16 mars 2023

Active
CéVéGé

Director · since 16 mars 2023 · 0888.599.974

Represented by Chris Verstraete

Active

Ended mandates

Bobbie Company

Managing director · since 16 mars 2023 · 0685.530.177

Represented by Benoit Devroe

Ended
Bobbie Company

Director · since 16 mars 2023 · 0685.530.177

Represented by Benoit DEVROE

Ended
CéVéGé

Director · since 16 mars 2023 · 0888.599.974

Represented by Chris Verstraete

Ended
VERGEL

Director · since 02 mai 2017 · 0812.259.489

Represented by Chris Verstraete

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date20/07/202610/07/202530/08/202428/09/202328/08/202230/08/2021
General meeting30/06/202627/06/202529/08/202412/05/202313/05/202214/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

15 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202620/07/2026DutchPDF
Full model31/12/202427/06/202510/07/2025DutchPDF
Abridged model31/12/202329/08/202430/08/2024DutchPDF
Abridged model31/12/202212/05/202328/09/2023DutchPDF
Abridged model31/12/202113/05/202228/08/2022DutchPDF
Abridged model31/12/202014/05/202130/08/2021DutchPDF
Abridged model31/12/201928/08/202011/11/2020DutchPDF
Abridged model31/12/201807/10/201924/10/2019DutchPDF
Abridged model31/12/201712/11/201812/11/2018DutchPDF
Abridged model31/12/201612/05/201731/08/2017DutchPDF
Abridged modelCorrection31/12/201508/05/201729/05/2017DutchPDF
Abridged model31/12/201513/05/201602/05/2017DutchPDF
Abridged model31/12/201408/05/201531/08/2015DutchPDF
Abridged model31/12/201309/05/201430/09/2014DutchPDF
Abridged model31/12/201210/05/201303/07/2013DutchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 11 ended

Active mandates

Bobbie Pharmaceutical Services

Managing director · since 19 août 2025 · 0799.344.237

Represented by Benoit Devroe

Active
Bobbie Company

Director · since 16 mars 2023 · until 19 août 2025 · 0685.530.177

Represented by Benoit Devroe

Active
Cecile Hoogmartens

Director · since 16 mars 2023

Active
CéVéGé

Director · since 16 mars 2023 · 0888.599.974

Represented by Chris Verstraete

Active

Ended mandates

Bobbie Company

Managing director · since 16 mars 2023 · 0685.530.177

Represented by Benoit Devroe

Ended
Bobbie Company

Director · since 16 mars 2023 · 0685.530.177

Represented by Benoit DEVROE

Ended
CéVéGé

Director · since 16 mars 2023 · 0888.599.974

Represented by Chris Verstraete

Ended
VERGEL

Director · since 02 mai 2017 · 0812.259.489

Represented by Chris Verstraete

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Dissolution12/02/2026
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202536,7 k €↓
  2. 2024
    Annual accounts 202490,8 k €↓
  3. 2023
    Annual accounts 2023181 k €↑
  4. 2022
    Annual accounts 202257,8 k €↑
  5. 2021
    Annual accounts 20214,8 k €↓
  6. 2020
    Annual accounts 202072 k €↑
  7. 2019
    Annual accounts 201916,9 k €↓
  8. 2018
    Annual accounts 201869,1 k €↑
  9. 2017
    Annual accounts 201750,4 k €↑
  10. 2016
    Annual accounts 20161,3 k €↑
  11. 2015
    Annual accounts 2015-57,3 k €↓
  12. 2014
    Annual accounts 201413,4 k €↑
  13. 2013
    Annual accounts 20138,7 k €↑
  14. 2012
    Annual accounts 20124,7 k €